All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Trastuzumab Deruxtecan in HER2 mBC
704 views
10 months ago
vumedi.com
Trastuzumab Cardiotoxicity in mBC: When to Restart HER2 Therapy?
…
49 views
May 28, 2023
vumedi.com
Use of Trastuzumab Deruxtecan in Ovarian Cancer
3 months ago
onclive.com
Dr. Esteva on Clinical Trial Design of Trastuzumab Biosimilar in HER
…
Sep 7, 2016
onclive.com
Trastuzumab deruxtecan versus trastuzumab emtansine in patient
…
Dec 22, 2022
onclive.com
Trastuzumab Deruxtecan in HER2 mCRC
Feb 20, 2023
onclive.com
3:04
Trastuzumab Deruxtecan for HER2 Breast Cancer
350 views
Mar 31, 2018
Facebook
OncLive
Final OS Data for Pembrolizumab Plus Trastuzumab/Chemotherapy
…
3 months ago
onclive.com
The Role of Trastuzumab Deruxtecan in HER2-Mutated NSC
…
9 months ago
onclive.com
Pertuzumab and Trastuzumab: Patient Eligibility, Administration
…
Oct 13, 2022
cancernetwork.com
2:30
Dr Janjigian on Pembrolizumab/Trastuzumab/Che
…
Oct 28, 2023
onclive.com
0:25
The introduction of the Pertuzumab-Trastuzumab combo for HER2 bre
…
1.6K views
Feb 4, 2024
Facebook
Vishwajit P RANE
ESMO 2024 Insights: Quantitative High Sensitivity HER2 Testing Wit
…
223 views
4 months ago
vumedi.com
Trastuzumab Deruxtecan for Patients With HER2 Metastatic Br
…
Nov 2, 2023
onclive.com
DESTINY-CRC02: Trastuzumab Deruxtecan in HER2 Metastatic Co
…
Jul 21, 2023
onclive.com
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer
…
Aug 5, 2022
mskcc.org
Dr. Messersmith on the Potential for Trastuzumab Deruxtecan in HER2
…
May 12, 2021
onclive.com
Dr. Basho on the Integration of Trastuzumab Deruxtecan in HER2
…
Jul 22, 2021
onclive.com
Dr. Tkaczuk on the Utilization of Trastuzumab Deruxtecan in HER2
…
Oct 5, 2022
onclive.com
Clinical Scenario 1: A HER2 mBC Patient With Trastuzumab Deruxte
…
1 month ago
onclive.com
SABCS 2023 Insights: "HER2CLIMB-05 Trial - Tucatinib
…
258 views
Dec 20, 2023
vumedi.com
Trastuzumab Deruxtecan in Patients With HER2 Advanced/Metastatic B
…
2 months ago
onclive.com
Dr. Extermann on the Utility of Trastuzumab Monotherapy in HER
…
Aug 11, 2021
onclive.com
Dr. Hurvitz on FDA Approval of Subcutaneous Trastuzumab Form
…
Mar 9, 2019
onclive.com
Dr Davis on the Investigation of Neratinib Plus Trastuzumab Derux
…
7 months ago
onclive.com
Ahli Sebut Akses Pasien Kanker Payudara ke Trastuzumab Terhala
…
5 months ago
kompas.com
Trastuzumab Deruxtecan in Patients With Metastatic Non-Small-Cell Lu
…
6 months ago
onclive.com
Dr Lobbous on Tucatinib Plus Trastuzumab/Capecitabine in HER
…
7 months ago
onclive.com
9:57
A Pooled Analysis of Trastuzumab Deruxtecan in Patients With HER
…
10 months ago
onclive.com
Effects of trastuzumab deruxtecan (T-DXd) on health-related quality o
…
1 month ago
onclive.com
See more videos
More like this
Feedback
Feedback